- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x XPW: 1-({(5S,7S)-3-[5-(2-hydroxypropan-2-yl)pyrazin-2-yl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl}methyl)-1H-benzimidazole-6-carbonitrile(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
MG.2: 6 residues within 4Å:- Chain B: T.19, P.36, T.37, V.38, A.61
- Ligands: GDP.3
2 PLIP interactions:2 interactions with chain B- Metal complexes: B:T.19, B:T.37
MG.4: 6 residues within 4Å:- Chain C: T.19, P.36, T.37, V.38, A.61
- Ligands: GDP.5
2 PLIP interactions:2 interactions with chain C- Metal complexes: C:T.19, C:T.37
MG.6: 6 residues within 4Å:- Chain D: T.19, P.36, T.37, V.38, A.61
- Ligands: GDP.7
2 PLIP interactions:2 interactions with chain D- Metal complexes: D:T.19, D:T.37
MG.8: 6 residues within 4Å:- Chain E: T.19, P.36, T.37, V.38, A.61
- Ligands: GDP.9
2 PLIP interactions:2 interactions with chain E- Metal complexes: E:T.19, E:T.37
- 4 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)
GDP.3: 16 residues within 4Å:- Chain B: D.13, G.14, A.15, C.16, G.17, K.18, T.19, C.20, F.30, V.35, K.118, L.121, S.160, A.161, K.162
- Ligands: MG.2
13 PLIP interactions:13 interactions with chain B- Hydrogen bonds: B:A.15, B:C.16, B:G.17, B:K.18, B:T.19, B:T.19, B:C.20, B:A.161, B:K.162
- Salt bridges: B:K.18
- pi-Stacking: B:F.30, B:F.30
- pi-Cation interactions: B:K.118
GDP.5: 16 residues within 4Å:- Chain C: D.13, G.14, A.15, C.16, G.17, K.18, T.19, C.20, F.30, V.35, K.118, L.121, S.160, A.161, K.162
- Ligands: MG.4
13 PLIP interactions:13 interactions with chain C- Hydrogen bonds: C:A.15, C:C.16, C:G.17, C:K.18, C:T.19, C:T.19, C:C.20, C:A.161, C:K.162
- Salt bridges: C:K.18
- pi-Stacking: C:F.30, C:F.30
- pi-Cation interactions: C:K.118
GDP.7: 16 residues within 4Å:- Chain D: D.13, G.14, A.15, C.16, G.17, K.18, T.19, C.20, F.30, V.35, K.118, L.121, S.160, A.161, K.162
- Ligands: MG.6
13 PLIP interactions:13 interactions with chain D- Hydrogen bonds: D:A.15, D:C.16, D:G.17, D:K.18, D:T.19, D:T.19, D:C.20, D:A.161, D:K.162
- Salt bridges: D:K.18
- pi-Stacking: D:F.30, D:F.30
- pi-Cation interactions: D:K.118
GDP.9: 16 residues within 4Å:- Chain E: D.13, G.14, A.15, C.16, G.17, K.18, T.19, C.20, F.30, V.35, K.118, L.121, S.160, A.161, K.162
- Ligands: MG.8
13 PLIP interactions:13 interactions with chain E- Hydrogen bonds: E:A.15, E:C.16, E:G.17, E:K.18, E:T.19, E:T.19, E:C.20, E:A.161, E:K.162
- Salt bridges: E:K.18
- pi-Stacking: E:F.30, E:F.30
- pi-Cation interactions: E:K.118
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kwon, D.H. et al., TRPV4-Rho GTPase complex structures reveal mechanisms of gating and disease. Nat Commun (2023)
- Release Date
- 2023-07-12
- Peptides
- Transient receptor potential cation channel subfamily V member 4: AFGH
Transforming protein RhoA: BCDE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AF
BG
CH
DB
EC
FD
GE
H - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x XPW: 1-({(5S,7S)-3-[5-(2-hydroxypropan-2-yl)pyrazin-2-yl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl}methyl)-1H-benzimidazole-6-carbonitrile(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 4 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kwon, D.H. et al., TRPV4-Rho GTPase complex structures reveal mechanisms of gating and disease. Nat Commun (2023)
- Release Date
- 2023-07-12
- Peptides
- Transient receptor potential cation channel subfamily V member 4: AFGH
Transforming protein RhoA: BCDE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AF
BG
CH
DB
EC
FD
GE
H - Membrane
-
We predict this structure to be a membrane protein.